Speaker Profile
Andrew Ishizuka

Andrew Ishizuka BS, MD, PhD

Immunology and Microbiology
Baltimore, Maryland, United States of America

Connect with the speaker?

Andrew Ishizuka, PhD, is co-founder and CSO of Avidea Technologies. In this role, Andrew leads pre-clinical animal testing and translational studies supporting the development of Avidea’s personalized cancer vaccine technology based on self-assembling nanoparticles. Prior to joining Avidea, Andrew was a post-doctoral fellow with Dr. Robert Seder at the Vaccine Research Center, NIH. Andrew attended medical school at Duke University and has a Ph.D. from the University of Oxford.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)